Post-Grant Options and Cost
Impact of PTAB
Joint Ventures and Dispute Resolution
Requirements to Receive a Patent
Implementing a Value-Driven Portfolio Process
Advantages of Registering a Trademark
How Should IP be Considered for Acquisition?
Open Source Initiative
What is a Patent?
Categories of Marks
Date of First Use
Contractual Intellectual Property Rights
Rewards of the Practice
Scope Concepts and Headnotes
Factors That Cause a Patent to Decline in Value
Marking a Product
Repeating Competitor Audits
Claim Maps and BioSimilars
IP Registration Density
Downside of Static Budget Allocation for Patents
"Claims" of a Patent
Joint Venture Pitfalls
PTAB Final Argument Trial Dynamics
Low Risk Joint Ventures
Importance of Freedom To Operate
Is A United States Registered Trademark Effective in Other Countries?
"How Much" - Audit Action Sheet
Do Narrow Patents Add Value to a Portfolio?
BioSimilar Patenting Litigation Involving Large Amounts of Money
Prior Art Challenge
High Risk Joint Ventures
Raising Good Prosecution Visibility
FDA Guidelines for Demonstrating Biosimilarity
A Less Expensive Alternative
Demonstrating BioSimilarity Under U.S. Law
Prior Art and Rejections
Patent Strategy Considerations
Different Parts of a Patent Document
Patent Profile Analytics and Engineers
What Does an Audit Action Sheet Look Like?
A Better Way to Allocate Patent Application Budgets
Open Source Software
Biologics vs Small Molecules
Process for Registering a Trademark in the United States
Hiring Patent Council
Independent Claim vs Dependent Claim
What Doesn't a Patent Provide?
How is Schwegman Lundberg & Woessner Different?
The Case of the Joint Marketing Agreement Gone Bad
Trademark Filing Considerations
Freedom to Operate
Important Attributes to Being a Successful Patent Lawyer
Impact of US Hatch Waxman Act 1984
Cost/Value Curve of a High Level Patent
How is Open Source Software Enforced?
What Makes Schwegman, Lundberg & Woessner Different?
How Does the Knowledge Gap Develop?
Approvals of BioSimilars in Europe
Patent Examination Process
Patent Profile Analytics and Researchers
Determining Likelihood of Confusion
Patents and Other Forms of Intellectual Property Protection
How do Patent Prosecution Services Vary in Value?
How Should IP be Considered for Growth?
Unlicensed Source Codes
Meet Mark Stignani
Merely Descriptive Refusal
Picking a Domain Name
Picking a Trademark
Why Should Claims Not Be Read on the Prior Art?
Proper Way to Use a Trademark
How is Open Source Incorporated into Software?
Intent of Patent Laws
Patent Citation Ranking
"Whens" - Audit Action Sheet
Trademarks and Brand Value
Mitigating Risks of Past Damages
Covered Business Method Review
What is a BioSimilar Product Under US Law?
Broad Patent Claim
Patent Trial and Appeal Board
Intellectual Property Protection
How is the Entire Patent Considered Prior Art?
Portfolio Dashboard - Inventor Information
Inventors and Patent Analytics
Am I Required to Search for Prior Art?
Domain Registration Considerations
Patent Ownership and Patent Profile Analytics
Post-Grant Proceedings and Patent Enforcement
Importance of Getting a Patent
How to Fix the Knowledge Gap
Forward Citation Landscape
The Advantage of Filing First
Cost/Value Curve of Patent a Portfolio
Purposes of a Trademark
Limiting Issues Defined in District Court
Trade Names vs Trademarks
Refused Trademark Recourse
Engineers Not Understanding Patents
How Much Does it Cost to Get a Patent?
Patent Profile Analytics and Managers
Common Reasons Trademarks Are Rejected
How Do Patent Portfolio Values Become Concentrated over Time?
Should IP be Part of Our Business Plan?
Forms of Confidential Information
Evaluation Agreement and Computer Codes
What is a Patent Portfolio?
Risks of Not Patenting
Audit Action Sheet
Confidential Information and Business Damage
Improperly Marked Product
Becoming a Patent Lawyer
Are BioSimilars Being Approved in the US?
5 Year View Point
PTAB Timing Trial Dynamics
Patent Status Updates
Effective Stay Strategy
Value Management Lifecycle
"Whats" - Audit Action Sheet
Freedom To Operate vs Clearance
Value Management and Risk Management
Inter Partes Review
Impact of Post-Grant Proceedings
Most Common Client Question
Two Main Value Drivers
What is a BioSimilar?
Infringing on Another Patent
Freedom to Operate (FTO) Process
Seeking Money from Investors
Why Do You Enjoy Being a Lawyer?
What Should a Company Patent?
What to Do When First Selecting a Mark
What is a Trademark?
Outside of Law
Challenges When Dealing with Patent Matters
Schwegman, Lundberg & Woessner - Chemicals and Pharmaceuticals
Practicing an Invention
Biologics Price Competition and Innovation Act
Tracking Work History
Calculating New Investments
Cited Art Landscape
Goal of a Value-Driven Patent Portfolio
What Do I Give up in Getting My Patent?
Joint Venture Ground Rules
Types of Inventions That Are Patentable
What is an Invention?
Types of Intellectual Property Protection
Steps to Obtaining a Patent
Litigation and BioSimilar Patenting
How to Navigate BioSimilar Challenges
Prior Art in Prosecution vs Prior Art in Litigation
Golden Rule of Auditing a Patent Portfolio
When to Do a Freedom to Operate
Benefits of Audit Action Sheet
Wasting Money on Low-Value Patents
Patents and Practicing an Invention
Renewing a Trademark Registration
Rebutting a Merely Descriptive Refusal
Is There Still a Place for Traditional Re-Examination?
What IP Should I Spend Money on First?
Helping In-House Council
Interpretational Differences Between Prosecution and Litigation
Value Management and Cash Flow
Naming Problems with BioSimilars
Joint Venture and Financial Agreements
Improving Patent Portfolio Value
How to Remedy Unwanted Disclosure of Confidential Information
Limited Valuable Patents in Technology Area
Get Your Assignments Straight - Contribution of Owners
Factors That Make a Patent Valuable
Auction Audit Sheet - Key Issues to Address
Using Product Association with IP Assets
Patent Portfolio and Budgets/Spending
NDAs and Customers
Assessing Executive Experience
Claim Abstraction Theory
Post-Grant Options and Estoppel
"Who" - Audit Action Sheet
Third Party Confidentiality
Importance of Post-Grant Proceedings
Provisional vs Non-Provisional Patent
Secondary Meaning of a Trademark
Why Is Executing an NDA Not Enough?
Qualifying for a Patent
Value-Driven Patent Portfolio
Standard for Getting a Patent
Why Are Biologicals so Important?
Consequences of Disclosing Confidential Information
Consequences of a Poorly Drafted Patent
Researching Competitors' IP
Infringement on the Rights of Other Patents
Geographic Insight and Patent Profile Analytics
NDAs and Computer Codes
Common Law Trademark Rights
Freedom To Operate
4 Ways to Prepare your Patent Portfolio for Battle.
Meet David Black
What Should a Company Understand at the End of an IP Audit?
When is a House like a Patent?
Attributes of a Good Patent
First Step in Performing a Patent Portfolio Audit
Tools for Auditing a Patent Portfolio
The Five Components of an Open Source Software Policy
Who Determines Substitution Factors?
Reasons to Consider Joint Ventures
Cost of Registering a Trademark
Ideal Patent Strategy
How Big Should My First Patent Be?
Moderate Risk Joint Ventures
Budgeting for Drafting and Prosecution
Attorneys and Patent Profile Analytics
How Does the Knowledge Gap Worsen Over Time?
Considerations Before Hiring IP Council
Equal Value Patents
How Long Does an FTO Take?
Patent Owner Rights
By the Numbers Overview
"Wheres" - Audit Action Sheet
Attorneys Not Understanding the Market
Patent Analytics and Competition
OSS Licensing Conditions
Schwegman Lundberg & Woessner & Post Grant Trial Practice
Trade Name Protection and Trademark Protection
Inventorship vs Ownership
How can OSS Negatively Affect a Company?
The Different Types of Marks
Segmenting a Portfolio
First Item on IP To-Do List
What is Prior Art?
Signing an NDA
Risks of OSS
What Engineers Can Learn from Patent Profile Analytics
Post-Grant Options and Grounds of Challenge
Discovering Annuity Information
Why Perform Risk Profile?